Loading stock data…
WAT
$307.12-2.11 (-0.68%)
Market ClosedLast close May 1
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Waters Corporation in the Healthcare sector is trading at $307.12. The stock is currently 26% below its 52-week high of $414.15, remaining 8.3% below its 200-day moving average. Technical signals show neutral RSI of 41 and bearish MACD signal, explaining why WAT maintains its current current market pressure. The Whystock Score of 70/100 reflects a high-conviction bullish alignment.
Ecosystem Influences
Neutral momentum (RSI 41) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$307.12
Potential Downside
25.4%
Whystock Fair Value$229.14
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus22 analysts
Buy
Mean target$385.50+25.5%
Range$330.00 – $470.00
Fundamentals
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spect...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$32.82B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
31.05
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.20
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
25.82%
Volume
Today's trading volume
619,574
Recent News
Teleflex (TFX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Teleflex (TFX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Waters (WAT) Beat Estimates Again in Its Next Earnings Report?
Waters (WAT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Waters (WAT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Waters (WAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
2 Large-Cap Stocks Worth Investigating and 1 We Question
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.
Becton Dickinson at 13x Earnings: MedTech's Most Mispriced Compounder
A leaner, pure-play MedTech leader emerges from the Waters spin-off with a 25% operating margin